USFDA pulls up Mylan for manufacturing violations at Andhra plant
Posted by
www.biotecnika.org
In a warning letter issued to the company's CEO Heather Bresch, the US
Food and Drug Administration (USFDA) said inspectors during May 27 to
June 5, this year found significant deviations from standard
manufacturing practices at the company's Unit 8 in G Chodavaram
village in Vizianagaram.
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/usfda-pulls-up-mylan-for-manufacturing-violations-at-andhra-plant/articleshow/72107827.cms
Subscribe to:
Post Comments (Atom)
Post a Comment